OKYO Pharma Limited (NASDAQ:OKYO) has a beta value of -0.09 and has seen 0.98 million shares traded in the recent trading session. The company, currently valued at $96.52M, closed the recent trade at $2.58 per share which meant it lost -$0.17 on the day or -6.20% during that session. The OKYO stock price is -20.54% off its 52-week high price of $3.11 and 68.6% above the 52-week low of $0.81. If we look at the company’s 10-day average daily trading volume, we find that it stood at 73210.0 shares traded. The 3-month trading volume is 160.75K shares.
The consensus among analysts is that OKYO Pharma Limited (OKYO) is Buy stock at the moment, with a recommendation rating of 1.00. 0 analysts rate the stock as a Sell, while 0 rate it as Overweight. 0 out of 1 have rated it as a Hold, with 1 advising it as a Buy. 0 have rated the stock as Underweight.
OKYO Pharma Limited (NASDAQ:OKYO) trade information
Sporting -6.20% in the red today, the stock has traded in the red over the last five days, with the highest price hit on recent trading when the OKYO stock price touched $2.58 or saw a rise of 16.77%. Year-to-date, OKYO Pharma Limited shares have moved 62.23%, while the 5-day performance has seen it change -11.66%. Over the past 30 days, the shares of OKYO Pharma Limited (NASDAQ:OKYO) have changed -14.30%. Short interest in the company has seen 0.19 million shares shorted with days to cover at 0.8.
OKYO Pharma Limited (OKYO) estimates and forecasts
The company’s shares have gained 150.44% over the past 6 months.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was -126.59% over the past 5 years.
OKYO Dividends
OKYO Pharma Limited is expected to release its next earnings report in August this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
OKYO Pharma Limited (NASDAQ:OKYO)’s Major holders
Insiders own 34.41% of the company shares, while shares held by institutions stand at 6.13% with a share float percentage of 9.35%. Investors are also buoyed by the number of investors in a company, with OKYO Pharma Limited having a total of 7.0 institutions that hold shares in the company.
